alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit








Exhibit 10.1


AMENDMENT NO. 1 TO THIRD AMENDED AND RESTATED
SYNOVUS FINANCIAL CORP. DEFERRED COMPENSATION PLAN




THIS AMENDMENT NO. 1 (this “Amendment”) TO THIRD AMENDED AND RESTATED SYNOVUS FINANCIAL CORP. DEFERRED COMPENSATION PLAN (the “Plan”) is entered into as of July 19, 2017.  Capitalized terms used in this Amendment and not otherwise defined shall have the meaning given to such terms in the Plan.


WHEREAS, Synovus Financial Corp. (“Synovus”) maintains the Plan;


WHEREAS, Synovus desires to amend the Plan to provide for separate elections to defer salary and bonuses, with such amendment to be effective on and after July 19, 2017;


NOW, THEREFORE, Synovus hereby amends the Plan as follows:


1.Amendments To Plan. 


		
	A.
	The second sentence of Section IV. A. subsection 2 of the Plan shall be deleted in its entirety and replaced with the following sentence in lieu thereof:  “The election form (or forms) shall provide for separate elections for salary and bonus and shall specify the whole percentage or flat dollar amount of each to be deferred.”




		
	B.
	The following new sentence shall be added immediately after the first sentence of Section IV. A. subsection 1 of the Plan:  “Notwithstanding the preceding sentence, with respect to bonus amounts which qualify as performance-based compensation under Code Section 409A, the Plan Administrator may permit deferral elections to be made as late as June 30 of the Plan Year in accordance with and subject to the requirements of Code Section 409A.” 


2.Benefits of this Amendment.  Nothing in this Amendment shall affect or diminish any Participant’s rights under the Plan or adversely affect any amount previously deferred under the Plan.
3. Governing Law.  This Amendment shall be governed by and construed under the laws of the State of Georgia.
4.Counterparts; Effectiveness.  This Amendment may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute one and the same instrument and shall become effective when each party hereto shall have received a counterpart hereof signed by all of the other parties hereto.  
5.Effect of Amendment.  Except as expressly modified by the Amendment, the Plan shall remain in full force and effect.  
IN WITNESS WHEREOF, Synovus has caused this Amendment No. 1 to be duly executed by its authorized officer as of the day and year first above written.




	
				
	 
	SYNOVUS FINANCIAL CORP.

	 
	 
	 

	August 4, 2017
	By:
	 
	/s/ Allan E. Kamensky

	Date
	 
	 
	Allan E. Kamensky

	 
	 
	 
	Executive Vice President, General Counsel and Secretary
**Exhibit 31.1**
   *Certification*
   I, J.
Leonard Ivins, certify that:
   1.  I have
reviewed this Form 10-QSB of Tabatha I, Inc.;
   2.  Based on
my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;
   3.  Based on
my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the small business issuer as of, and
for, the periods presented in this report;
   4.  The small
business issuer's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
small business issuer and have:
   a.  Designed
such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material
information relating to the small business issuer, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;
   b.  Designed
such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
generally accepted accounting principles; and
   c.  Evaluated
the effectiveness of the small business issuer's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation.
   5.  The small
business issuer's other certifying officer(s) and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
small business issuer's auditors and the audit committee of the small business
issuer's board of directors (or persons performing the equivalent
functions):
   a.  All
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to
adversely affect the small business issuer's ability to record, process,
summarize and report financial information; and
   b.  Any
fraud, whether or not material, that involves management or other employees who
have a significant role in the small business issuer's internal control over
financial reporting.
  Date: May
31, 2005
 
 
 /s/ 
J. Leonard Ivins_____________________
 J.
Leonard Ivins, Principal Executive Officer and
 Principal
Financial and Accounting Officer
Declarations on the Equity Interest



 EXHIBIT 4. 142 
 Declarations on the Equity Interest in Beijing Yi Lian Tong He Information Technology Co., Ltd on behalf of TOM EACHNET HOLDINGS (BVI) INC. 
 I, Wei Hong Jun, a PRC citizen whose ID number is 452701197505200510 and residence address is No. 32, Hechi Street, Hechi Town, Hechi City, Guangxi Province , hereby make the representations concerning the
shareholdings in Beijing Yi Lian Tong He Information Technology Co., Ltd on behalf of TOM EACHNET HOLDINGS (BVI) INC. (the “Trustor”) (whose registered address is P.O. Box 173, Kingston Chambers, Road Town, Tortola, British Virgin Islands)
as follows: 
  

	1.	I executed a Trust Deed on Feb 1, 2007 and hold equity interest in Beijing Yi Lian Tong He Information Technology Co., Ltd on behalf of the Trustor in my own name (the “Trusted
Equity”). 

  

	2.	I hereby admit that the Trusted Equity of such trust was contributed by the Trustor in my own name, and the property and proceeds arising from it were attributed to the Trustor. I
didn’t pay any fees or considerations for the Trusted Equity. 

  

	3.	I confirm that, besides holding the Trusted Equity in my own name on behalf of the Trustor, I do not have the right to use or dispose the Trusted Equity or collect proceeds accrued
thereon and such Trusted Equity is not contributed to my property or the property jointly owned by me and my spouse during the period from the establishment of this trust to the termination of this trust. 

  

	4.	I confirm that the Trusted Equity shall be separated from my property or the property jointly owned by me and my spouse. In particular, when I encounter disputes, litigations,
arbitrations, or administrative punishment, or if I shall lose civil capacity in part or in whole, disappear or die, the Trustor’s right of such Trusted Equity will not be changed, restricted, or impaired by any of the aforesaid events.


  

	5.	I hereby beforehand confirm that once any of the aforesaid events occurs, the Trustor shall be entitled to decide how to dispose such Trusted Equity concurrently. I and/or the
property trustee, and/or my successors shall not propose any objection in relation to it. 

 All the aforesaid representations reflect my
genuine intention, and there is no fraud, compulsion, misrepresentation, unfairness, collusion, or violation of law. These representations are effective until my death and I guarantee that I there would be no change or regret. 
 Hereby certified. 
  

	
	 Representor:

	
	 Name: Wei Hong Jun

	 Date: Feb 1, 2007
**Exhibit 32.1**

 

 

 

 

 

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

 

**PURSUANT TO 18 U.S.C. SECTION 1350,**

 

**AS ADOPTED PURSUANT TO**

 

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

 

 

In connection with the Annual Report of ProText Mobility, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Peter Charles, Principal Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

 

1.           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

 

2.           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

| Date: April 16, 2012

*/s/ Peter Charles*

 

Peter Charles

 

Principal Executive Officer

 

 

The foregoing certification accompanied the Annual Report on Form 10-K filing pursuant to 18 U.S.C. § 1350.  It is being reproduced herein for information only.  It is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and it is not to be incorporated by reference into any filing of the Company, whether made before or after hereof, regardless of any general incorporation language in such filing.  A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

  |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
# C_2020227EN.01000401.xml

| 10.7.2020 | EN | Official Journal of the European Union | C 227/4 |
| --- | --- | --- | --- |

10.7.2020

EN

Official Journal of the European Union

C 227/4

---

Non-opposition to a notified concentration

(Case M.9783 – EQT/OMERS/DGF/INEXIO)

(Text with EEA relevance)

(2020/C 227/04)

On 29 April 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9783. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9783. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
Joseph J. DEMTY, Appellant(s)/Petitioner(s), v. U.S. BANK NATIONAL ASSOCIATION, etc., Appellee(s)/Respondent(s),

CASE NO.: 3D18-0863

District Court of Appeal of Florida, Third District.

JULY 12, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
Jerome DICKEY, Appellant, v. STATE of Florida, Appellee.

No. 1D17-2909

District Court of Appeal of Florida, First District.

September 26, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Reported Emissions and Product Content 

Table 1. Reported Emissions and Product Content of PFOA, Precursors, and Higher Homologues from U.S. Operations 

Company Sixth 

Reporting 

Year 

Chemical 

Category 

Emissions Product Content 

Releases to all 

media from FP 

and Telomer 

Manufacturing

(kg)

kg of 

release / kg 

of product 

produced 

Dispersions

(ppm wetweight basis)

Other 

Fluoropolymers

(ppm dry-weight 

basis)

Telomers 

(ppm dryweight basis, 

unless stated 

otherwise)

Asahi 2013 

PFOA, PFOA 

salts and 

Higher 

Homologues 

0 Not 

Applicable 0 0 Not Applicable 

Precursors Not Applicable 
Table 2. Reported Emissions and Product Content of PFOA, Precursors, and Higher Homologues from Non U.S. Operations 

Company Sixth 

Reporting 

Year 

Chemical 

Category 

Emissions Product Content 

Releases to all 

media from FP 

and Telomer 

Manufacturing 

(kg)

kg of 

release / kg 

of product 

produced 

Dispersions

(ppm wetweight basis)

Other 

Fluoropolymers

(ppm dry-weight 

basis)

Telomers 

(ppm dryweight basis, 

unless stated 

otherwise)

Asahi 2013 

PFOA, PFOA 

salts and 

Higher 

Homologues 

20.1 

For FP 

Production: 

< 1 kg / 100 

kg 

Not 

Applicable 18 

Negligible 

compared to 

precursors 

Precursors 0 

For Telomer 

Production: 

< 1 kg / 100 

kg 

Not 

Applicable Not Applicable 

Average 

50% (range: 

0-100%) 
Reported Percent Reductions in Emissions and Product Content 

Table 3. Reported Percent Reductions in Emissions and Product Content of PFOA, Precursors, and Higher Homologues from

U.S. Operations 

Company 

Sixth 

Reporting 

Year 

Chemical 

Category 

% Reduction in Emissions % Reduction in Product Content 

% Reductions in total 

quantity of chemical(s) 

released from baseline year

Fluoropolymer 

Dispersions 

Other 

Fluoropolymers 

Telomer based 

products 

Asahi 2013 

PFOA, 

PFOA salts 

and Higher 

Homologues 

100% 100% 100% Not Applicable 

Precursors Not Applicable 
Table 4. Reported Percent Reductions in Emissions and Product Content of PFOA, Precursors, and Higher Homologues from 

Non U.S. Operations 

Company 

Sixth 

Reporting 

Year 

Chemical 

Category 

% Reduction in Emissions % Reduction in Product Content 

% Reductions in total 

quantity of chemical(s) 

released from baseline year

Fluoropolymer 

Dispersions 

Other 

Fluoropolymers 

Telomer based 

products 

Asahi 2013 

PFOA, 

PFOA salts 

and Higher 

Homologues 

99.8% 100% 99.9% 

Negligible as 

compared to 

precursors 

Precursors 100% Not Applicable Not Applicable 100% 
Accomplishment Table 

Company Facilities Reductions 

 Emissions Product Content 

US 100% 100% 

Non-US 99.9% 100% 

Global 99.9% 100%
Ramiro RODRIGUEZ, Appellant, v. The STATE of Florida, Appellee.

No. 3D18-763

District Court of Appeal of Florida, Third District.

Opinion filed August 8, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
| 1. | Such      Quarterly Report on Form 10-Q for the six and three months ending      December 31, 2009 fully complies with the requirements of section 13(a) or      15(d) of the Securities Exchange Act of 1934;  and |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | The      information contained in such Quarterly Report on Form 10-Q for      the six and three months ending December 31, 2009, fairly presents,      in all material respects, the financial condition and results of      operations of Longwei Petroleum Investment Holding  Limited. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                                         |   |   |   |   |
|----------------------------------------------|--------|--------|--------|--------|
| By: /s/  James      Crane               |   |   |   |   |
| James      CraneChief      Financial Officer |   |   |   |   |
|                                         |   |   |   |   |
NOTE: This disposition is nonprecedential.

 

United States Court of Appeals 

for the Federal Circuit ______________________ 

IN RE: POLARIS EXECUTIVE CENTER, LLC, DBA 

GENESIS VILLAGE,

Appellant

______________________ 

2022-1119

______________________ 

Appeal from the United States Patent and Trademark 

Office, Trademark Trial and Appeal Board in No. 

88624647.

______________________ 

JUDGMENT

______________________ 

ARNOLD BRAUN, Law Department, Medical Diagnostic 

Laboratories, Hamilton, NJ, argued for appellant Polaris 

Executive Center, LLC. 

 BENJAMIN T. HICKMAN, Office of the Solicitor, United 

States Patent and Trademark Office, Alexandria, VA, argued for appellee Katherine K. Vidal. Also represented by 

THOMAS L. CASAGRANDE, CHRISTINA J. HIEBER, THOMAS W.

KRAUSE, FARHEENA YASMEEN RASHEED. 

 ______________________ 

THIS CAUSE having been heard and considered, it is 

ORDERED and ADJUDGED: 

Case: 22-1119 Document: 43 Page: 1 Filed: 01/17/2023
 PER CURIAM (NEWMAN, CHEN, and CUNNINGHAM, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

 

 ENTERED BY ORDER OF THE COURT 

 

January 17, 2023 

Date

/s/ Peter R. Marksteiner

Peter R. Marksteiner

Clerk of Court

Case: 22-1119 Document: 43 Page: 2 Filed: 01/17/2023
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Tabatha I, Inc. (the "Company") on Form 10-QSB for the
period ending September 30, 2004 (the "Report"), I, John Ballard, President and Chief Financial Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

> 1) The Report fully complies with the requirement of Section 13(a) or 15 (d) of the Securities Exchange
> Act of 1934; and
> 
> 
> 2) The information contained in the Report fairly presents, in all material respects, the Company's
> financial position and results of operations.

/s/John Ballard



 John Ballard,

 President and Chief Financial Officer

November 15, 2004
February ii, 2013

U.S. Environmental Protection Agency Office of Air and Radiation Stratospheric Protection Division Attention: Melissa Fiffer 1310 L Street NW, ioth Floor Washington, DC 20005 Dear Ms. Fiffer:

Request for Further Information for SNAP Submission for

Request from Agency: i. Clarification of blend compositions. The new substitute is proposed for use neat and in blends of as little as The actual blend formulation has the potential to vary widely. Please specify, or at least narrow, the chemicals and percentage of the chemicals to be used in blends for the solvent cleaning (metal, electronic, and precision cleaning), aerosol (solvent), and adhesives, coatings, and ink uses.i~'14:' 8 ?

### Request from Agency:

2. Conversion of exposure estimates. In your PowerPoint presentation, you provided estimates of human exposure to the proposed substitute in units of mg/kg/day. Please confirm or correct the conversion from mg/kg/day to ppm. We estimated these values based on the following equation: Exposure Estimate x 72 / io x 2 4•45 In addition, please clarify whether these exposure estimates are based on the neat substance only or on a



### Request from Agency: 3. Additional toxicity information. Do you have any 28-day or 9o-day inhalation toxicity studies completed for this compound that you could provide? If you have not performed such a study, we request that you perform at least a 28-day inhalation toxicity study. If you conduct additional testing, we recommend that the testing include a functional observation battery on neurological effects. As inhalation is the most probable route of exposure, a repeat dose inhalation study would be helpful in fully assessing health effects and reducing uncertainty.



### Request from Agency: 4. Confidential business information (CBI) claims. Claims of CBI, if you wish to claim any of the information above as CBI. Page ;Response from submitter:

The submitter does wish to claim certain information as CBI. The CBI information has been clearly marked. Confidential and public copies are enclosed.

Attachment 1 Via Federal Express Page }r

~--~ ~ ~
~ ~ V (LS
~ El
Owen D. DENSON, Jr. a/k/a Hakim Shabazz, Appellant/Petitioner(s), v. Julie JONES, Secretary and State of Florida, Appellee/Respondent(s).

CASE NO.: 2D17-4139

District Court of Appeal of Florida, Second District.

November 27, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Denied.
Lydia DEGUEYTER v. FIRST AMERICAN TITLE COMPANY

No. 2017-C-2163

Supreme Court of Louisiana.

September 18, 2018

**ON WRIT OF CERTIORARI TO THE COURT OF APPEAL, THIRD CIRCUIT, PARISH OF ST. MARTIN**

PER CURIAM

Having considered the record, oral argument and briefs of the parties, we find the court of appeal correctly reversed the district court's judgment granting summary judgment in favor of First American Title Co. However, we find the court of appeal erred in granting summary judgment in favor of plaintiff. *See**Penalber v. Blount* , 550 So.2d 577 (La. 1989) (explaining that summary judgment "is rarely appropriate for a determination based on subjective facts such as intent, motive, malice, knowledge or good faith."). Accordingly, the judgment of the court of appeal is affirmed in part and reversed in part. The motions for summary judgment filed by both parties are hereby denied, and the case is remanded to the district court for further proceedings.

GENOVESE, J., dissenting in part.

I agree with the majority that the court of appeal erred in granting summary judgment in favor of Linda Degueyter. However, I *disagree* with the majority that the court of appeal correctly reversed the trial court's grant of summary judgment in favor of First American Title Company (First American).

Resolution of First American's motion for summary judgment requires an interpretation and application of its *owner's* title insurance policy. First American's motion for summary judgment does *not* , as the majority concludes, require a determination of "subjective facts such as intent, motive, malice, knowledge or good faith." *Penalber v. Blount* , 550 So.2d 577, 583 (La.1989). Rather, summary judgment in favor of First American is appropriate because there are no genuine issues of material fact as to the lack of coverage in favor of Degueyter under the title insurance policy, and the insurer is entitled to judgment as a matter of law. La.Code Civ.P. art. 966. For these reasons, I find the court of appeal erred in reversing the trial court's grant of summary judgment in favor of First American.

Accordingly, I respectfully dissent in part.